Peter M Ten Klooster (P M Ten Klooster, Peter Ten Klooster)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2013-2024
Publications (10 Years): 29

Top Venues

Expert opinion on drug safety

Journal of happiness studies

Rheumatology advances in practice

Health and quality of life outcomes

University of Twente

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Twente Dec 01 2008

Netherlands

Assistant Professor :: Psychology, Health and Technology

Publications

Janneke M Quik, Helen R Gosselt, Jette A van Lint, Leanne J Kosse, Peter M Ten Klooster, Harald E Vonkeman, Bartholomeus J F van den Bemt, Naomi T Jessurun
The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of concept. Expert opinion on drug safety (2024)
Benthe H König, Helen R Gosselt, Jette A van Lint, Leanne J Kosse, Bartholomeus J F van den Bemt, Peter M Ten Klooster, Harald E Vonkeman, Naomi T Jessurun
Quantification of longitudinal patient-reported burden of adverse drug reactions attributed to the use of TNF-α inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study. Expert opinion on drug safety (2024)
Peter M Ten Klooster, Jorge Piano Simoes, Harald E Vonkeman
Limited content overlap between commonly used self-report instruments for central (pain) sensitization in rheumatology. Rheumatology advances in practice 8 (3) (2024)
Ernst Thomas Bohlmeijer, L Frielingsdorf, Jannis T Kraiss, E de Jager-Meezenbroek, Anja Visser, Peter M Ten Klooster
Spirituality in the Context of Well-being. Evaluation of the Psychometric Properties and Added Value of the Spiritual Attitude and Involvement List Short Form (SAIL-SF). Journal of happiness studies 24 (3) (2023)
Kimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, Joep H G Scholl, Jurriaan R G Jansen, Jette A van Lint, Leanne J Kosse, Peter M Ten Klooster, Harald E Vonkeman
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept. Expert opinion on drug safety (2023)
Ernst Thomas Bohlmeijer, L Frielingsdorf, Jannis T Kraiss, E de Jager-Meezenbroek, Anja Visser, Peter M Ten Klooster
Spirituality in the Context of Well-being. Evaluation of the Psychometric Properties and Added Value of the Spiritual Attitude and Involvement List Short Form (SAIL-SF). Journal of happiness studies 24 (3) (2023)
Ernst Thomas Bohlmeijer, L Frielingsdorf, Jannis T Kraiss, E de Jager-Meezenbroek, Anja Visser, Peter M Ten Klooster
Spirituality in the Context of Well-being. Evaluation of the Psychometric Properties and Added Value of the Spiritual Attitude and Involvement List Short Form (SAIL-SF). Journal of happiness studies 24 (3) (2023)
Kimberly Velthuis, Fenna Poppelaars, Peter M Ten Klooster, Harald E Vonkeman, Naomi T Jessurun
Impact of adverse drug reactions on the treatment pathways of early rheumatoid arthritis patients: a prospective observational cohort study. Expert opinion on drug safety (2023)
Anne Gorter, Mark Matthijs Bakker, Peter M Ten Klooster, Annelies Boonen, Harald E Vonkeman
The impact of health literacy: associations with disease activity and medication prescription in patients with rheumatoid arthritis. Rheumatology (Oxford, England) (2023)
Niels Jansen, Peter M Ten Klooster, Harald E Vonkeman, Boudewijn van den Berg, Jan R Buitenweg
Further evaluation of inflammatory and non-inflammatory aspects of pain in rheumatoid arthritis patients. Rheumatology advances in practice 7 (3) (2023)
Kimberly Velthuis, Fenna Poppelaars, Peter M Ten Klooster, Harald E Vonkeman, Naomi T Jessurun
Impact of adverse drug reactions on the treatment pathways of early rheumatoid arthritis patients: a prospective observational cohort study. Expert opinion on drug safety (2023)
Kimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, Joep H G Scholl, Jurriaan R G Jansen, Jette A van Lint, Leanne J Kosse, Peter M Ten Klooster, Harald E Vonkeman
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept. Expert opinion on drug safety (2023)
Niels Jansen, Peter M Ten Klooster, Harald E Vonkeman, Frans C T van der Helm
Test-Retest Reliability of the Generalized Pain Questionnaire in Patients with Rheumatoid Arthritis and Preliminary Reference Values for Non-Clinical and Several Clinical Samples. Journal of pain research 16 (2023)
Kimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, Joep Scholl, Jurriaan R G Jansen, Jette A van Lint, Leanne J Kosse, Peter M Ten Klooster, Harald E Vonkeman
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept. Expert opinion on drug safety (2023)
Peter M Ten Klooster, Jannis T Kraiss, Rik Munters, Harald E Vonkeman
Generalized pain hypersensitivity and associated factors in gout. Rheumatology (Oxford, England) 61 (9) (2022)
Johannes J Rasker, Frederick Wolfe, Ewa G Klaver-Krol, Machiel J Zwarts, Peter M Ten Klooster
The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures. PloS one 16 (2) (2021)
Esther Beckers, Marin Been, Casper Webers, Annelies Boonen, Peter M Ten Klooster, Harald E Vonkeman, Astrid van Tubergen
Performance of 3 Composite Measures for Disease Activity in Peripheral Spondyloarthritis. The Journal of rheumatology (2021)
Jette A van Lint, Tom Bakker, Peter M Ten Klooster, Eugene P van Puijenbroek, Harald E Vonkeman, Naomi T Jessurun
Neuropsychiatric adverse drug reactions associated with low dose methotrexate in rheumatoid arthritis patients. Expert opinion on drug safety (2021)
Renate Catharina Wilhelmina Johanna Willems, Constance Hélene Christine Drossaert, Peter M Ten Klooster, Harald Miedema, Ernst Bohlmeijer
The Role of Self-Compassion in the Job Demands-Resources Model, an Explorative Study among Crisis Line Volunteers. International journal of environmental research and public health 18 (18) (2021)
Inger L Abma, Bas J D Butje, Peter M Ten Klooster, Philip Jan van der Wees
Measurement properties of the Dutch-Flemish patient-reported outcomes measurement information system (PROMIS) physical function item bank and instruments: a systematic review. Health and quality of life outcomes 19 (1) (2021)
Esther Beckers, Casper Webers, Annelies Boonen, Peter M Ten Klooster, Harald E Vonkeman, Astrid van Tubergen
Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands. Clinical rheumatology 39 (10) (2020)
Eline L Giraud, Naomi T Jessurun, Florence P A M van Hunsel, Eugene P van Puijenbroek, Astrid van Tubergen, Peter M Ten Klooster, Harald E Vonkeman
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients. Expert opinion on drug safety 19 (12) (2020)
Peter M Ten Klooster, Yvonne C M Rensen, Jorrit F Postma, Roy P C Kessels
Development and preliminary evaluation of the QUALIKO: an observational quality of life instrument for patients with Korsakoff's syndrome. Health and quality of life outcomes 18 (1) (2020)
Marjan Ghiti Moghadam, Femke B G Lamers-Karnebeek, Harald E Vonkeman, Peter M Ten Klooster, Janneke Tekstra, Barbara van Schaeybroeck, Ruth Klaasen, Marieke van Onna, Hein J Bernelot Moens, Henk Visser, Annemarie M Schilder, Marc R Kok, Robert B M Landewé, Piet L C M van Riel, Mart A F J van de Laar, Tim L Jansen, null null
Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment. BMC rheumatology 3 (2019)
Peter M Ten Klooster, Letty G A Versteeg, Martijn A H Oude Voshaar, Inmaculada de la Torre, Francesco De Leonardis, Walid Fakhouri, Liliana Zaremba-Pechmann, Mart van de Laar
Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Arthritis research & therapy 21 (1) (2019)
Jannis T Kraiss, Peter M Ten Klooster, Melissa Chrispijn, Anja W M M Stevens, Ralph W Kupka, Ernst Thomas Bohlmeijer
Psychometric properties and utility of the Responses to Positive Affect questionnaire (RPA) in a sample of people with bipolar disorder. Journal of clinical psychology 75 (10) (2019)
Jannis T Kraiss, Peter M Ten Klooster, Melissa Chrispijn, Anja W M M Stevens, Ralph W Kupka, Ernst Thomas Bohlmeijer
Measuring personal recovery in people with bipolar disorder and exploring its relationship with well-being and social role participation. Clinical psychology & psychotherapy 26 (5) (2019)
Peter M Ten Klooster, Martijn A H Oude Voshaar, Walid Fakhouri, Inmaculada de la Torre, Claudia Nicolay, Mart A F J van de Laar
Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy. Clinical rheumatology 38 (10) (2019)
Marion Sommers-Spijkerman, Hester Trompetter, Peter M Ten Klooster, Karlein Schreurs, Paul Gilbert, Ernst Bohlmeijer
Development and validation of the forms of Self-Criticizing/Attacking and Self-Reassuring Scale-Short Form. Psychological assessment 30 (6) (2017)
Hester R Trompetter, Peter M Ten Klooster, Karlein M G Schreurs, Martine Fledderus, Gerben J Westerhof, Ernst T Bohlmeijer
Measuring values and committed action with the Engaged Living Scale (ELS): psychometric evaluation in a nonclinical sample and a chronic pain sample. Psychological assessment 25 (4) (2013)

Peter M Ten Klooster.css-eqlu8i{font-size:small;padding-left:4px;} (P M Ten Klooster, Peter Ten Klooster)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter M Ten Klooster (P M Ten Klooster, Peter Ten Klooster)